Commercial Operations

Cost of Insulin Doubled as Usage Stayed Flat, Says HCCI

Insulin costs nearly doubled from 2012 to 2016, even as usage remained stable, according to a new analysis from the Health Care Costs Institute (HCCI) — a non-profit funded in part by Aetna, Humana, Kaiser Permanente and UnitedHealthcare. Read More

NYC, Massachusetts Cite Sackler Family’s Role in Opioid Crisis

Both New York City and the Massachusetts Attorney General’s office have set their sights on the family behind Purdue Pharma, alleging the Sackler family continued to push Oxycontin despite detailed knowledge of the overdoses, addiction and deaths the product was causing. Read More

BMS to Create Oncology Drug Powerhouse with Celgene Acquisition

Similarly, Celgene’s blood cancer drug Imnovid/Pomalyst (pomalidomide) saw sales of $513 million in the third quarter, a 23 percent year-over-year increase, and its non-small cell lung cancer treatment Abraxane (paclitaxel) saw revenues increase by 15 percent year-over-year to $288 million. Read More